(Q38182297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Immune modulation in humans: implications for type 1 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Bart O Roep

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

28 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

229-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Regulatory T cells under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

The role of different subsets of T regulatory cells in controlling autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Regulatory T cells: recommendations to simplify the nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Central role for interleukin-2 in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Expansion of human regulatory T-cells from patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Analysis of islet inflammation in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Regulatory T cells in infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Helminth infections and host immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Reversal of autoimmunity by boosting memory-like autoregulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Infectious tolerance as candidate therapy for type 1 diabetes: transfer of immunoregulatory properties from human regulatory T cells to other T cells and proinflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Autoreactive and immunoregulatory T-cell subsets in insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Anti-TNF treatment in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Factors associated with early remission of type I diabetes in children treated with cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

New hope for immune intervention therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

The effect of the MHC locus on autoantibodies in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Immune intervention therapy in type 1 diabetes: safety first.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Current advances and travails in islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Infectious tolerance via the consumption of essential amino acids and mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

"Infectious" transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Treg cells, life history, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

The role of cytokines (and not only) in inducing and expanding T regulatory type 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Islet inflammation and CXCL10 in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Cutting Edge: Increased IL-17-Secreting T Cells in Children with New-Onset Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Transfer of regulatory properties from tolerogenic to proinflammatory dendritic cells via induced autoreactive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Pathologic anatomy of the pancreas in juvenile diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Can we change the course of beta-cell destruction in type 1 diabetes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Immunogenetic and clinical characterization of slowly progressive IDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Translating mucosal antigen based prevention of autoimmune diabetes to human.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.2

IL-10-producing regulatory B cells (B10 cells) in autoimmune disease

31 March 2020

1 reference

12 December 2020

Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes

1 reference

12 December 2020

Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases

1 reference

12 December 2020

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2014.2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24468651%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference